Sage Therapeutics (NASDAQ ... The restructuring, set to be completed by Q4 2024, will impact over 165 employees (around 33% ...
Sage’s board of directors said that the proposal “significantly undervalues” the company and is not in the best interest of ...
Sage Therapeutics' CFO to leave, drugmaker to lay off over 165 employees October 17, 2024 Sage Therapeutics said on Tuesday it would stop developing its experimental drug, dalzanemdor, for ...
On Friday, Sage Therapeutics Inc. (NASDAQ ... The company’s layoff impacted over 165 employees (approximately 33% of its total workforce and approximately 55% of its R&D workforce), including ...